Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Current Assets (2024 - 2026)

Updated

Hemab Therapeutics Holdings (COAG) recorded Current Assets of $438.16 million in Q3 2026, down 5.6% from the prior quarter.

Analysis

Hemab Therapeutics Holdings (COAG) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Hemab Therapeutics Holdings reported Current Assets of $192.55 million, up 106.5% from FY2024.

  • Across earlier years, Current Assets came in at $93.24 million in FY2024.
  • Quarterly Current Assets has ranged from $93.24 million in Q4 2024 to $464 million in Q2 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $464 million (Q2 2026), $169.43 million (Q1 2026) and $192.55 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 56.35 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 37.48 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 31.45 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 16.55 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 45.01 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - 438.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 438.16 Mn
Jun 30, 2026 464.00 Mn
Mar 31, 2026 169.43 Mn
Dec 31, 2025 192.55 Mn
Dec 31, 2024 93.24 Mn
API Access

Hemab Therapeutics Holdings Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=COAG&period=max&api_key=YOUR_API_KEY